OBJECTIVE: To compare the ADHD combined/hyperactive subtype (ADHD/CH) to the ADHD inattentive subtype (ADHD/I) on the level of comorbidity, treatment response, and possible etiological factors. METHOD: A total of 371 clinically referred children diagnosed with ADHD aged between 6 and 12 years are recruited for a double-blind, placebo-controlled trial of methylphenidate. Comorbidity, treatment response, and stress during pregnancy are assessed for each participant. Genotyping is done for the DAT, DRD4, and 5-HTT genes. Mothers report smoking or alcohol consumption during their pregnancy and their child's birth weight. RESULTS: The ADHD/CH children show both a higher frequency of conduct disorder and good response to treatment, are exposed to more moderate stress during their mothers' pregnancy, and show a higher frequency of L/L genotype for the 5-HTT-linked polymorphic region. CONCLUSION: The significant differences found between the ADHD/CH and the ADHD/I subtypes raise the possibility that the two may be separate disorders.
RCT Entities:
OBJECTIVE: To compare the ADHD combined/hyperactive subtype (ADHD/CH) to the ADHD inattentive subtype (ADHD/I) on the level of comorbidity, treatment response, and possible etiological factors. METHOD: A total of 371 clinically referred children diagnosed with ADHD aged between 6 and 12 years are recruited for a double-blind, placebo-controlled trial of methylphenidate. Comorbidity, treatment response, and stress during pregnancy are assessed for each participant. Genotyping is done for the DAT, DRD4, and 5-HTT genes. Mothers report smoking or alcohol consumption during their pregnancy and their child's birth weight. RESULTS: The ADHD/CH children show both a higher frequency of conduct disorder and good response to treatment, are exposed to more moderate stress during their mothers' pregnancy, and show a higher frequency of L/L genotype for the 5-HTT-linked polymorphic region. CONCLUSION: The significant differences found between the ADHD/CH and the ADHD/I subtypes raise the possibility that the two may be separate disorders.
Authors: Stephane A Beaudin; Barbara J Strupp; Walter Uribe; Lauren Ysais; Myla Strawderman; Donald R Smith Journal: Neurotoxicol Teratol Date: 2017-03-28 Impact factor: 3.763
Authors: Robert E McKeown; Joseph R Holbrook; Melissa L Danielson; Steven P Cuffe; Mark L Wolraich; Susanna N Visser Journal: J Am Acad Child Adolesc Psychiatry Date: 2014-11-11 Impact factor: 8.829
Authors: Tanya E Froehlich; Stephen P Becker; Todd G Nick; William B Brinkman; Mark A Stein; James Peugh; Jeffery N Epstein Journal: J Clin Psychiatry Date: 2018 Mar/Apr Impact factor: 4.384
Authors: John T Mitchell; Elizabeth M McIntyre; Joseph S English; Michelle F Dennis; Jean C Beckham; Scott H Kollins Journal: J Atten Disord Date: 2013-12-04 Impact factor: 3.256